Complement Therapeutics
Clinical trials sponsored by Complement Therapeutics, explained in plain language.
-
New injection aims to slow vision loss from dry AMD
Disease control Recruiting nowThis study tests a new treatment called CTx001 for people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes vision loss. The treatment is given as a single injection under the retina. The study will check if it is safe and if it can slow…
Phase: PHASE1, PHASE2 • Sponsor: Complement Therapeutics • Aim: Disease control
Last updated May 17, 2026 07:22 UTC
-
Eye disease study tracks how vision loss worsens over time
Knowledge-focused Recruiting nowThis study watches how geographic atrophy, a form of advanced age-related macular degeneration, changes over a short period. Researchers will measure vision and eye structure in 75 people aged 55 or older. The goal is to better understand how the disease progresses and what facto…
Sponsor: Complement Therapeutics • Aim: Knowledge-focused
Last updated May 17, 2026 07:20 UTC